10x Genomics Inc (NAS:TXG)
$ 24.41 -0.42 (-1.69%) Market Cap: 2.92 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.06 GF Score: 75/100

10X Genomics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 13, 2021 / 06:45PM GMT
Release Date Price: $169 (-8.40%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Thank you for joining us today on day 3 of our Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. I'm delighted to have 10x join us today and representing the company, we have Serge Saxonov, CEO; and Justin McAnear, CFO. Welcome guys.

Before I get started, just have a quick safe harbor to read here. Important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that Serge, I mean, it's been a busy year for 10x. So maybe just to set the stage, can you give us a brief overview of what you think are the company's sort of greatest accomplishments here to date? And how do you view sort of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot